Skip to content

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation

Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00785720
Enrollment
26
Registered
2008-11-05
Start date
2008-08-31
Completion date
2008-09-30
Last updated
2009-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDETINBACK Sweet Flower.

Interventions

Sponsors

Sanofi
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Phototype Skin II and III; * Integral skin test in the region; * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

* Lactation or gestation * Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection; * Diseases which can cause immunity decrease, such as HIV, diabetes; * Use of drug photosensitizer; * History of sensitivity or irritation for topic products; * Active cutaneous disease which can change the study results; * History of photodermatosis active; * Family or personal antecedent of cutaneous photoinduced neoplasias; * Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and queratoses actinium; * Intense solar exposure in the study area; * Use of new drugs or cosmetics during the study The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Design outcomes

Primary

MeasureTime frame
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.Throughout the study

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026